UTAH MEDICAL PRODUCTS INC
For the period ended Dec 31, 2025. Filed Mar 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 27, 2026
UTMD$72.86-0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Balance Sheets
| UTAH MEDICAL PRODUCTS, INC. | ||||||
|---|---|---|---|---|---|---|
| CONSOLIDATED BALANCE SHEETS | ||||||
| December 31, 2025 and 2024 | ||||||
| (In thousands) | ||||||
| 2025 · 2024 | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash | $85,756 | $82,976 | ||||
| Accounts and other receivables, net (note 2) | 3,522 | 4,094 | ||||
| Inventories (note 2) | 7,935 | 8,812 | ||||
| Prepaid expenses and other current assets | 529 | 448 | ||||
| Total current assets | 97,742 | 96,330 | ||||
| Property and equipment, net (notes 4 and 10) | 9,908 | 9,763 | ||||
| Goodwill | 14,052 | 13,580 | ||||
| Other intangible assets (note 2) | 55,941 | 53,772 | ||||
| Other intangible assets - accumulated amortization | (55,101) | (50,907) | ||||
| Other intangible assets - net (note 2) | 840 | 2,865 | ||||
| Total assets | $122,542 | $122,538 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
| Current liabilities: | ||||||
| Accounts payable | $911 | $696 | ||||
| Accrued expenses (note 2) | 1,687 | 3,061 | ||||
| Total current liabilities | 2,598 | 3,757 | ||||
| Long term lease liability | 225 | 282 | ||||
| Deferred tax liability - intangible assets | 114 | 603 | ||||
| Deferred income taxes (note 7) | 337 | 469 | ||||
| Total liabilities | 3,274 | 5,111 | ||||
| Commitments and contingencies (notes 6 and 12) | - | - | ||||
| Stockholders' equity: | ||||||
| Common stock, $0.01 par value; 50,000 shares authorized, issued 3,186 shares in 2025 and 3,335 shares in 2024 | 32 | 33 | ||||
| Accumulated other comprehensive loss | (9,416) | (11,908) | ||||
| Additional paid-in capital · - · - | ||||||
| Retained earnings | 128,652 | 129,302 | ||||
| Total stockholders' equity | 119,268 | 117,427 | ||||
| Total liabilities and stockholders' equity | $122,542 | $122,538 | ||||
| See accompanying notes to financial statements. | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.